ホーム>>Natural Products>>Complanatuside

Complanatuside

カタログ番号GC33795

Complanatuside は、伝統的な漢方薬 Semen Astragali Complanati に含まれるフラボノイドです。

Products are for research use only. Not for human use. We do not sell to patients.

Complanatuside 化学構造

Cas No.: 116183-66-5

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$101.00
在庫あり
5mg
$73.00
在庫あり
10mg
$110.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Complanatuside is a flavonoid found in the traditional Chinese medicine Semen Astragali Complanati.

Semen Astragali Complanati (SAC), the dried ripe seed of Flatstem Milkvetch (Astragalus complanatus Bunge), is commonly used in traditional Chinese medicine for treating muscle, liver, kidney, blood, skin and reproductive system diseases. The major contents of SAC include fatty acids, amino acids, polysaccharides, flavonoids, triterpene glycosides and trace elements. SAC exhibits a number of therapeutic effects on chronic diseases such as cardiovascular diseases, diabetes mellitus and cancers. It has been found that flavonoids are the main bioactive component in SAC[1][2].

[1]. Ng YF, et al. Semen Astragali Complanati: an ethnopharmacological, phytochemical and pharmacological review. J Ethnopharmacol. 2014 Aug 8;155(1):39-53. [2]. Ng YF, et al. Semen Astragali Complanati: an ethnopharmacological, phytochemical and pharmacological review. J Ethnopharmacol. 2014 Aug 8;155(1):39-53.

レビュー

Review for Complanatuside

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Complanatuside

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.